Looking for Rituximab found 14 matches
|
| Open monograph to display formulary status |
BNF Category |
| |
 Rituximab
|
Malignant disease and immunosuppression - Anti-lymphocyte monoclonal antibodies - 08.02.03
|
| |
Rituximab
|
Nutrition and blood - Drugs used in hypoplastic, haemolytic, and renal anaemias - 09.01.03
|
| |
Rituximab
|
Nutrition and blood - Drugs used in autoimmune thrombocytopenic purpura - 09.01.04
|
| |
Rituximab
(Biosimilars avaliable)
|
Musculoskeletal and joint diseases - Cytokine modulators - 10.01.03
|
| |
Links Link to Drug Section  Link to document |
|
LSCMMG: Rituximab Intravenous Infusion for the Treatment of Autoimmune Haemolytic Anaemia (AIHA) in Adults NMR (09.01.03)
|
|
LSCMMG: Rituximab Intravenous Infusion For treatment of Idiopathic Thrombocytopenia Purpura (ITP) in adults NMR (09.01.04)
|
|
MHRA: Rituximab: screen for hepatitis B virus before treatment (10.01.03)
|
|
MHRA: Rituximab: screen for hepatitis B virus before treatment (09.01.03)
|
|
MHRA: Rituximab: screen for hepatitis B virus before treatment (09.01.04)
|
|
NICE TA195: Adalimumab, etanercept, infliximab, rituximab and abatacept for the treatment of rheumatoid arthritis after the failure of a TNF inhibitor (10.01.03)
|
|
NICE TA195:Adalimumab, etanercept, infliximab, rituximab and abatacept for the treatment of rheumatoid arthritis after the failure of a TNF inhibitor (10.01.03)
|
|
NICE TA195:Adalimumab, etanercept, infliximab, rituximab and abatacept for the treatment of rheumatoid arthritis after the failure of a TNF inhibitor (10.01.03)
|
|
NICE TA195:Adalimumab, etanercept, infliximab, rituximab and abatacept for the treatment of rheumatoid arthritis after the failure of a TNF inhibitor (10.01.03)
|
|
NICE TA195:Adalimumab, etanercept, infliximab, rituximab and abatacept for the treatment of rheumatoid arthritis after the failure of a TNF inhibitor (10.01.03)
|
|
|
